as 09-11-2025 4:00pm EST
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Founded: | 1984 | Country: | United States |
Employees: | N/A | City: | PROVO |
Market Cap: | 572.2M | IPO Year: | 1996 |
Target Price: | $6.88 | AVG Volume (30 days): | 525.1K |
Analyst Decision: | Hold | Number of Analysts: | 2 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 2.03 | EPS Growth: | N/A |
52 Week Low/High: | $5.32 - $12.40 | Next Earning Date: | 11-06-2025 |
Revenue: | $1,626,325,000 | Revenue Growth: | -11.79% |
Revenue Growth (this year): | -11.55% | Revenue Growth (next year): | 0.98% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Nathanson Laura | NUS | Director | Sep 4 '25 | Sell | $12.22 | 6,489 | $79,295.58 | 33,149 | |
Clark Chayce David | NUS | EVP and General Counsel | Sep 3 '25 | Sell | $11.97 | 20,000 | $239,400.00 | 233,140 | |
CAMPBELL DANIEL W | NUS | Director | Aug 29 '25 | Sell | $12.11 | 32,437 | $392,668.62 | 39,216 |
NUS Breaking Stock News: Dive into NUS Ticker-Specific Updates for Smart Investing
Business Wire
2 months ago
Business Wire
3 months ago
Simply Wall St.
3 months ago
StockStory
3 months ago
Business Wire
3 months ago
Simply Wall St.
4 months ago
Simply Wall St.
4 months ago
GuruFocus.com
4 months ago
The information presented on this page, "NUS Nu Skin Enterprises Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.